➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Express Scripts
Baxter
Merck
McKesson

Last Updated: June 18, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ZILRETTA

« Back to Dashboard

All Clinical Trials for Zilretta

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03529942 Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee Recruiting Flexion Therapeutics, Inc. Phase 3 2018-04-24 This is an open-label study assessing the effect of the administration of a single intra-articular (IA) injection of FX006 32 mg on synovial volume in patients with osteoarthritis (OA) of the knee.
NCT03895840 The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OA Recruiting University of Kansas Medical Center Phase 4 2018-03-19 This study will be an open-label trial to determine the functional effects of bilateral IA injections of Zilretta into knee joints of 70 subjects with bilateral KL grade 2-4 symptomatic knee osteoarthritis (OA). Measurement and evaluation of outcomes at baseline, 6, 12 and 24 weeks will allow assessment of short and long-term effects, consistent with Osteoarthritis Research Society International (OARSI) and Outcome Measures in Rheumatology (OMERACT) recommendations.
NCT04160091 Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis Recruiting Medpace, Inc. Phase 2 2019-11-07 This is a double-blind study to evaluate the efficacy and safety of FX006 in patients with glenohumeral osteoarthritis (OA) or shoulder adhesive capsulitis (AC).
NCT04160091 Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis Recruiting Flexion Therapeutics, Inc. Phase 2 2019-11-07 This is a double-blind study to evaluate the efficacy and safety of FX006 in patients with glenohumeral osteoarthritis (OA) or shoulder adhesive capsulitis (AC).
NCT04182672 Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis Not yet recruiting Flexion Therapeutics, Inc. Phase 2 2020-01-06 The purpose of this study is to determine the safety and efficacy of Zilretta (FX006) in bursal injections and to assess the patient's impression to change in treatments, to their chronic pain.
NCT04182672 Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis Not yet recruiting The University of Texas Health Science Center, Houston Phase 2 2020-01-06 The purpose of this study is to determine the safety and efficacy of Zilretta (FX006) in bursal injections and to assess the patient's impression to change in treatments, to their chronic pain.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Zilretta

Condition Name

Condition Name for Zilretta
Intervention Trials
Osteoarthritis, Knee 3
Adhesive Capsulitis 2
Knee Osteoarthritis 2
Osteoarthritis of the Shoulder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Zilretta
Intervention Trials
Osteoarthritis, Knee 4
Osteoarthritis 4
Bursitis 3
Inflammation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Zilretta

Trials by Country

Trials by Country for Zilretta
Location Trials
United States 12
United Kingdom 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Zilretta
Location Trials
California 2
North Carolina 2
Illinois 1
Virginia 1
Kentucky 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Zilretta

Clinical Trial Phase

Clinical Trial Phase for Zilretta
Clinical Trial Phase Trials
Phase 4 1
Phase 3 1
Phase 2 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Zilretta
Clinical Trial Phase Trials
Not yet recruiting 4
Recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zilretta

Sponsor Name

Sponsor Name for Zilretta
Sponsor Trials
Flexion Therapeutics, Inc. 4
University of Virginia 1
Austin V Stone 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Zilretta
Sponsor Trials
Industry 6
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
AstraZeneca
McKinsey
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.